Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies. We use options pricing models to derive market expectations for stock movement over different time periods.
GP-Act III Acquisition Corp. (GPAT) is trading at $10.83 as of April 7, 2026, marking a 0.18% decline from its prior closing price. This analysis covers key technical levels, recent market context for the special purpose acquisition company (SPAC) sector, and potential near-term scenarios for GPAT, as investor focus on pre-merger acquisition vehicles remains sensitive to both broader market risk sentiment and potential corporate update announcements. No recent earnings data is available for GPAT
Are short sellers targeting GP-Act III (GPAT) Stock | Price at $10.83, Down 0.18% - Diversification
GPAT - Stock Analysis
3308 Comments
565 Likes
1
Stephanye
Influential Reader
2 hours ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
👍 179
Reply
2
Clelia
Returning User
5 hours ago
The outcome is spectacular!
👍 22
Reply
3
Nihirareddy
Experienced Member
1 day ago
That idea just blew me away! 💥
👍 60
Reply
4
Arienette
Active Reader
1 day ago
Market breadth shows divergence, highlighting selective strength in certain sectors.
👍 69
Reply
5
Lindwood
Legendary User
2 days ago
A real inspiration to the team.
👍 129
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.